Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
See Latest ArticlesSerum Creatinine and Prostate Cancer Risk in a Prospective Study
Cancer Epidemiology, Biomarkers & Prevention, 09/18/09
Weinstein SJ et al. – Prospectively measured serum creatinine, within normal ranges, is positively related to prostate cancer risk. Future research should reexamine the association in other populations, including any interrelationship with serum prostate–specific antigen.
Related Articles
Changes in serum creatinine in the first 24 hours after cardiac arrest indicate prognosis: an observational cohort study
Critical Care, 11/03/09
Relevance Score: 69%
Cystatin C is a sensitive marker for detecting a reduced glomerular filtration rate when assessing chronic kidney disease in patients with rheumatoid arthritis and secondary amyloidosis
Scandinavian Journal of Rheumatology, 10/02/09
Relevance Score: 67%
Serum cystatin C level is a good prognostic marker in patients with cirrhotic ascites and normal serum creatinine levels
Liver International, 10/08/09
Relevance Score: 66%
Diffusion-weighted MR imaging of kidneys in patients with systemic lupus erythematosus: initial experience
Rheumatology International, 10/14/09
Relevance Score: 65%
Male gender results in more severe lupus nephritis
Rheumatology International, 10/05/09
Relevance Score: 65%
Today in Renal/Urologic...keeping you current
Receive free subspecialty "5-minute updates" via email
Management of patients with advanced bladder cancer following major response to systemic chemotherapy
Expert Review of Anticancer Therapy, 12/04/09
Degarelix 240/80 mg: a new treatment option for patients with advanced prostate cancer
Expert Review of Anticancer Therapy, 12/04/09
The choice of the antigen in the dendritic cell-based vaccine therapy for prostate cancer
Cancer Treatment Reviews, 12/04/09
Sponsor
Article Search
Sponsor
Sponsor